ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

J010D In force

CASPOFUNGINUM

◀ Back 📄 CNAS document

The protocol name and text are reproduced in Romanian, exactly as published by CNAS.

Sublist / disease code

C1-G10, C2 - P9

reimbursement list

Continuation by the family doctor

Listed since

November 2025

position 109 in the order

Last amended

November 2025

1 versions since November 2025

Medicines

From the protocol title (medicines of the protocol) and other substances mentioned in the text (combinations, previous treatments, interactions)

Medicines of the protocol

CASPOFUNGINUM 15 products

Brand products authorised in Romania

From the ANMDM register, for the medicines of the protocol

CASPOFUNGINUM 15 products

List of products (15 presentations)

INN	Brand name	Form	Strength	Holder	ATC	Rx
CASPOFUNGINUM	CASPOFUNGINA DEMO 50 mg	PULB. PT. CONC. PT. SOL. PERF.	50mg	DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA	J02AX04	PR
CASPOFUNGINUM	CASPOFUNGINA DEMO 70 mg	PULB. PT. CONC. PT. SOL. PERF.	70mg	DEMO S.A. PHARMACEUTICAL INDUSTRY - GRECIA	J02AX04	PR
CASPOFUNGINUM	CASPOFUNGINA KABI 50 mg	PULB. PT. CONC. PT. SOL. PERF.	50mg	FRESENIUS KABI ROMANIA SR.L. - ROMANIA	J02AX04	PR
CASPOFUNGINUM	CASPOFUNGINA KABI 70 mg	PULB. PT. CONC. PT. SOL. PERF.	70mg	FRESENIUS KABI ROMANIA SR.L. - ROMANIA	J02AX04	PR
CASPOFUNGINUM	CASPOFUNGINA ROMPHARM 50 mg	PULB. PT. CONC. PT. SOL. PERF.	50mg	ROMPHARM COMPANY S.R.L. - ROMANIA	J02AX04	PR
CASPOFUNGINUM	CASPOFUNGINA SANDOZ 50 mg	PULB. PT. CONC. PT. SOL. PERF.	50mg	SANDOZ PHARMACEUTICALS S.R.L. - ROMANIA	J02AX04	PR
CASPOFUNGINUM	CASPOFUNGINA SANDOZ 70 mg	PULB. PT. CONC. PT. SOL. PERF.	70mg	SANDOZ PHARMACEUTICALS S.R.L. - ROMANIA	J02AX04	PR
CASPOFUNGINUM	CASPOFUNGINA STADA M&D 50 mg	PULB. PT. CONC. PT. SOL. PERF.	50mg	STADA M&D SRL - ROMANIA	J02AX04	PR
CASPOFUNGINUM	CASPOFUNGINA STADA M&D 70 mg	PULB. PT. CONC. PT. SOL. PERF.	70mg	STADA M&D SRL - ROMANIA	J02AX04	PR
CASPOFUNGINUM	CASPOFUNGINA TERAPIA 50 mg	PULB. PT. CONC. PT. SOL. PERF.	50mg	TERAPIA S.A. - ROMANIA	J02AX04	PR
CASPOFUNGINUM	CASPOFUNGINA TERAPIA 70 mg	PULB. PT. CONC. PT. SOL. PERF.	70mg	TERAPIA S.A. - ROMANIA	J02AX04	PR
CASPOFUNGINUM	CASPOFUNGINA VIATRIS 50 mg	PULB. PT. CONC. PT. SOL. PERF.	50mg	VIATRIS LIMITED - IRLANDA	J02AX04	PR
CASPOFUNGINUM	CASPOFUNGINA VIATRIS 70 mg	PULB. PT. CONC. PT. SOL. PERF.	70mg	VIATRIS LIMITED - IRLANDA	J02AX04	PR
CASPOFUNGINUM	CASPOFUNGINA ZENTIVA 50 mg	PULB. PT. CONC. PT. SOL. PERF.	50mg	ZENTIVA K.S. - REPUBLICA CEHA	J02AX04	PR
CASPOFUNGINUM	CASPOFUNGINA ZENTIVA 70 mg	PULB. PT. CONC. PT. SOL. PERF.	70mg	ZENTIVA K.S. - REPUBLICA CEHA	J02AX04	PR

History

The versions of the protocol from the Ministry of Health / CNAS orders, with medicines added / removed and the changed text

November 2025 baseline listlista protocoalelor terapeutice NOIEMBRIE 2025 D-L (2)

Protocol text (version of November 2025, in Romanian)

Protocol terapeutic corespunzător poziţiei nr. 109, cod (J010D): DCI CASPOFUNGINUM Indicaţii - sepsis cu scor Carmeli 2 sau 3 - neutropenia febrilă Evaluarea riscului - Carmeli • A. Contactul cu sectorul sanitar: 1) Fără contact 1 2) Contact fără proceduri invazive 2 3) Contacte repetate cu proceduri invazive 3 • B. Tratament AB: 1) Fără AB 1 2) Cu AB în antecedente 2 • C. Caracteristicile pacientului: 1) Tânăr - fără comorbidităţi 1 2) Vârstnic cu comorbidităţi 2 3) Pacient imunodeprimat: 3 - AIDS - BPOC - Cancer - BMT Tratament Schema de tratament: Se iniţiază tratamentul cu Caspofungin şi după identificarea agentului etiologic se aplică principiul dezescaladării, folosind agentul antifungic cel mai activ Doze: - 70 mg IV în prima zi, apoi 50 mg/zi.

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.